MTOR and influenza: Down-regulation of mTOR activity by rapamycin, GSK-3 by lithium, or MEK by trametinib can each individually extend lifespan in laboratory organisms (5, , , , , –11), and brief inhibition of mTOR has recently been shown to increase the response of elderly people to immunization against influenza (12).